Managing patients undergoing non-cardiac surgery: Need to shift emphasis from risk stratification to risk modification

Heart

Volumn 92, Issue 1, 2006, Pages 17-20

  Karthikeyan, Ganesan ^a   Bhargava, B ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

CLINICAL TRIAL; CORONARY ARTERY DISEASE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; PERIOPERATIVE PERIOD; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SURGICAL TECHNIQUE;

ADRENERGIC BETA-ANTAGONISTS; ALGORITHMS; CORONARY ARTERIOSCLEROSIS; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; PERIOPERATIVE CARE; RISK ASSESSMENT; RISK FACTORS;

EID: 29644441141     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2004.057125     Document Type: Review

References (30)

1. Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977;297:845-50.
2. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999;100:1043-49.
3. Boersma E, Poldermans D, Bax JJ, et al for the DECREASE Study Group. Predictors of cardiac events after major vascular surgery: role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy. JAMA 2001;285:1865-73.
4. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery-executive summary. J Am Coll Cardiol 2002;39:542-53.
5. Bodenheimer MM. Noncardiac surgery in the cardiac patient: what is the question? Ann Intern Med 1996;124:763-6.
6. Mold JW, Stein HF. The cascade effect in the clinical care of patients. N Engl J Med 1986;314:512-14.
7. Ober KP. Uncle Remus and the cascade effect in clinical medicine: Brer Rabbit kicks the Tar-Baby. Am J Med 1987;82:1009-13.
8. Sisson JC, Schoonmaker EB, Ross JC. Clinical decision analysis: the hazard of using additional data. JAMA 1976;236:1259-63.
9. Grayburn PA, Hillis DL. Cardiac events in patients undergoing noncardiac surgery: shifting the paradigm from noninvasive risk stratification to therapy. Ann Intern Med 2003;138:506-11.
10. Palda VA, Detsky AS. Perioperative assessment and management of risk from coronary artery disease. Ann Intern Med 1997;127:313-28.
11. Lee TH, Boucher CA. Clinical practice: noninvasive tests in patients with stable coronary artery disease. N Engl J Med 2001;344:1840-5.
12. Fuster V, Badimon L, Badimon JJ, et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med 1992;326:242-50.
13. Dawood MM, Gutpa DK, Southern J, et al. Pathology of fatal perioperative myocardial infarction: implications regarding pathophysiology and prevention. Int J Cardiol 1996;57:37-44.
14. Cohen MC, Aretz TH. Histological analysis of coronary artery lesions in fatal postoperative myocardial infarction. Cardiovasc Pathol 1999;8:133-9.
15. Mangano DT, Hollenberg M, Fegert G, et al. Perioperative myocardial ischemia in patients undergoing noncardiac surgery - I: Incidence and severity during the 4 day perioperative period. The study of perioperative ischemia (SPI) research group. J Am Coll Cardiol 1991;17:843-50.
16. Ellis SG, Hertzer NR, Young JR, et al. Angiographic correlates of cardiac death and myocardial infarction complicating major nonthoracic vascular surgery. Am J Cardiol 1996;77:1126-8.
17. Massie BM, Mangano DT. Assessment of perioperative risk: have we put the cart before the horse. J Am Coll Cardiol 1993;21:1353-6.
18. Mason JJ, Owens DK, Harris RA, et al. The role of coronary angiography and coronary revascularization before noncardiac vascular surgery. JAMA 1995;273:1919-25.
19. Eagle KA, Rihal CS, Mickel MC, et al. Cardiac risk of noncardiac surgery: influence of coronary disease and type of surgery in 3368 operations. Circulation 1997;96:1882-7.
20. Foster ED, Davis KB, Carpenter JA, et al. Risk of noncardiac operation in patients with defined coronary disease: the coronary artery surgery study (CASS) registry experience. Ann Thorac Surg 1986;41:42-50.
21. Posner KL, Van Norman GA, Chan V. Adverse cardiac outcomes after noncardiac surgery in patients with prior percutaneous transluminal coronary angioplasty. Anesth Analg 1999;89:553-60.
22. Kaluza GL, Joseph J, Lee JR, et al. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 2000;35:1288-94.
23. McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004;364:1519-21.
24. McFalls EO, Ward HB, Moritz TE, et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 2004;351:2795-804.
25. Mangano DT, Layug EL, Wallace A, et al. The multicenter study of perioperative ischemia research group. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med 1996;335:1713-21.
26. Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch echocardiographic cardiac risk evaluation applying stress echocardiography study group. N Engl J Med 1999;341:1789-94.
27. Nissen SE, Tsunoda T, Tuzcu EM, et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 2003;290:2292-300.
28. O'Neil-Callahan K, Katsimaglis G, Tepper MR, et al. Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery: the statins for risk reduction in surgery (StaRRS) study. J Am Coll Cardiol 2005;45:336-42.
29. Kertai MD, Boersma E, Westerhout CM, et al. A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery. Eur J Vasc Endovasc Surg 2004;28:343-52.
30. Durazzo AE, Machado FS, Ikeoka DT, et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg 2004;39:967-75.